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This study was undertaken to determine the fate of circulating NH2-terminal propeptide of type 
I procollagen (PlNP) in rats.  P,  adiolabded PINP showed a biphasic serum decay curve after 
intravenous injection. 79% of the material disappeared from the blood during the initial c~-phase 
(tl/2c~ =  0.6 min), while the remaining 21% was eliminated with a tl/213 of 3.3 rain. The major 
site of uptake was the liver, 78, 1, and 21% of its radioactivity being recovered in isolated liver 
endothdial cells (LEC), Kupffer calls, and parenchymal calls, respectively. In LEC, fluorescently 
labeled PINP accumulated in small (0.1/zm) peripheral and larger (>0.1 #m) perinuclear vesicles 
within 10 rain at 37~  after a binding pulse at 4~  These grew in size with increasing chasing 
time, reaching a maximum diameter of 1/zm or more after 30 rain, and taking the shape of 
rings that were stained only along their periphery. At chase intervals exceeding 30 min, the 
size of the vesicles decreased,  and after 60 min the stain  appeared  in smaller,  densely stained 
perinudearly located vesicles. Degradation of tzsI-PINP to free smaller fragments and 12sI- was 
significant after 30 min. Only formaldehyde-treated albumin, acetylated LDL, polyinosinic acid 
and NH2-terminal propeptide of type III procollagen (PIIINP) competed with PlNP for uptake. 
These findings indicate that clearance of PINP and PIIINP, which are normal waste products 
generated in large quantities, is a physiological function of the scavenger receptor in LEC. 
T 
ype I collagen is the most abundant collagen species in 
soft tissues and accounts for >90% of the organic ma- 
trix of mineralized bone. It is synthesized in the form of a 
larger protein, type I procollagen, which contains large ad- 
ditional domains at both ends (1). These parts, known as 
the NH2- and COOH-terminal propeptides of type I pro- 
collagen, are removed by two spedfic proteinases in the ex- 
tracdlular space. Proper cleavage of these precursor-specific 
parts of the molecule is a prerequisite for the appropriate as- 
sembly of type I collagen molecules into collagen fibrils and 
fibers (2). 
Although collagen makes up about 30% of all animal pro- 
tein, literature dealing with the catabolism of this protein 
and its propeptides is not extensive. Since the serum concen- 
tration of these substances is very low, powerful mechanisms 
evidently exist to eliminate these molecules. NH2-terminal 
propeptide of type I procollagen (PINP) 1 exists in two forms 
1 Abbreviations used in this paper: AcLDL, acetyhted light density lipo- 
protein;  Kay, relative  elution position;  KC,  Kapffer cell;  LDL,  light 
density lipoprotein; LEC, liver endothelial cell; PC, parenchymal ceU; PICP, 
COOH-terminal propeptide of type I procollagen;  PlNP, NH2-terminal 
propeptide of type I procollagen;  PIIINP, NHz-terminal propeptide of 
type III procollagen;  Poly I, polyinosinic  acid; TC, tyraminyl cellbiose. 
in  serum:  the  native trimeric  PINP  (35,000  Mr),  and  a 
smaller related to its NH2-terminal Coll domain (7,000 Mr), 
the former predominating. There is no solid evidence to sug- 
gest that local breakdown is responsible for the catabolism 
of these peptides. 
We have recently found that gelatinized collagens of sev- 
eral  types  and  the  NH2-terminal  propeptide of type  III 
procollagen (PIIINP), as well as the COOH-terminal propep- 
tide of type I procollagen (PICP), are cleared from the circu- 
lation et~ciently and almost exclusively by receptor-mediated 
endocytosis in sinusoidal liver endothelial cells (LEC) (3, 4). 
We show here that also the PINP is eliminated by the same 
cells in the rat, identify the receptor involved in this process 
as the scavenger receptor, and describe the specifidty, kinetics, 
and morphology of endocytosis, and intracdlular transport 
and degradation of PINP. 
Materials and Methods 
Ligands.  Human (5), bovine (6), and porcine (7) PIIINP and 
human type I collagen (8) were purified as described previously. 
To prepare PINP, type I procollagen was first purified from the 
culture medium of human osteosarcoma  MG-63 cell line (Amer- 
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ammonium sulfate  and gel filtration on Sephacryl  S-500 (Pharmacia, 
Uppsala, Sweden). The procolhgen was digested  with purified  bac- 
terial coUagenase  (grade  CLSPA;  Wort~ngton Biochem  Corp., Free- 
hold, NJ). PINP was purified from the digest by anion exchange 
HPLC (Protein-Pak  DEAE-5FW column; Waters Associates, Mil- 
lipore Corp., Milford, MA), gel filtration on Sephacryl  S-300 (Phar- 
macia), and reverse phase HPLC (Vydac, Hesperia, CA).  PlNP 
purified in this manner was injected intradermally into rabbits to 
produce antiserum,  which was used for assay  and further purification 
of PINP from human ascitic fluid. SDS-PAGE revealed a 14,000- 
Mr major band representing the NHz-terminal segment of the 
proal(I) chain, and a 7,000-Mr minor band representing the NHr 
terminal segment of the proo~2(I) chain. The molecular weights 
were obtained by comparison with collagenous standards. Healon 
(high molecular weight  hyaluronan) was from Pharmacia, and 
heparin (free glycosaminoglycan  chains) was a gift from Professor 
U. Lindahl (University of Uppsah, Uppsala, Sweden). Formalde- 
hyde-treated  bovine serum albumin (FSA) and acetyhted light den- 
sity lipoprotein (AcLDL)  were prepared exactly  as described (9-11). 
Polyinosinic  acid (Poly I) was purchased from Sigma Chemical Co. 
(St. Louis, MO); nsI was from Amersham International, Amer- 
sham, Bucks, UK). 
Labeling Techniques.  Proteins  were hbeled with 12sI (carrier-free 
NanSI from Amersham International) either by a direct reaction 
employing Iodobeads (Pierce, Rockford, IL) as described (12), or 
by conjugating the protein with l~I-labded tyraminyl cellobiose 
(TC) exactly as described (3). LDL and AcLDL were labeled only 
with the latter method. Either method gave specific  radioactivities 
of 1-3  x  106 cpm//~g protein, nsI labeling of tyrosine was done 
by the Iodobeads method. On the basis of hydrophobic interaction 
with the gel material, l~I-labeled tyrosine was purified free of un- 
bound lZSI  by elution through a column of Sephadex G-25. FITC- 
labeled PlNP was prepared by incubating PlNP (1 mg/ml) with 
FITC (1 mg/ml) in 0.5 M sodium bicarbonate buffer (pH 9.5) for 
20 h at  +4~  Unreacted dye was removed by gel filtration on 
a PD-10 column (Sephadex G-25; Pharmacia). 
Determination of Anatomical Distribution and Serum tl/2.  Serum 
half-life,  and organ and hepatocellular  distribution of intravenously 
administered labeled PINP were determined in rats as described 
(13). leI- or nSI-TC-hbeled PINP (5/~g) was injected into a lateral 
tail vein. Blood sampling was started after 1 rain by collecting 25- 
/zl volumes from the tip of the tail into calibrated capillary tubes. 
To determine the c~- and/3- phases of the elimination from blood, 
about six samples were taken per minute during the first 5 min, 
and two samples per minute thereafter. 
Isolation and Culture of Liter Cells.  Preparation  of  pure cultures 
of functionally intact Kupffer cells (KC), LEC, and parenchymal 
cells (PC) from a single rat liver has been detailed elsewhere (14). 
After collagenase  perfusion of the liver, and isopycnic  centrifuga- 
tion of the resulting dispersed cells through Percoll (Pharmacia), 
pure monolayer  cultures of  KC and LEC were established  by sdec- 
tire attachment on substrates of fibronectin and glutaraldehyde- 
treated serum albumin, respectively  (15). PC were made free from 
sinusoidal cells by sedimentation through 50% Percoll. 
Endocytosis Studies In Vitr&  LEC cultures, established in 2-cm  ~ 
wells and maintained in sernm-free RPMI 1640 medium, were 
washed and supplied with fresh medium containing 1% serum al- 
bumin and labeled proteins. Incubations carried out for various 
lengths of time at  +37~  to measure endocytosis or at  +4~  to 
measure binding, were terminated by transferring the media, along 
with one wash, to tubes containing 20% TCA. This precipitates 
only intact, undegraded protein or intermediate degradation prod- 
ucts of high molecular weight. The extent of degradation was de- 
termined by measuring the radioactivities in pellet and superna- 
tant after centrifugation. Cell-associated  ligand was quantified by 
measuring the amount of label solubilized in PBS containing 1% 
SDS. 
Pulse-chase Studies on  Kinetics  of  Uptake  and  Degradation In 
Vitro.  Monolayer  cultures of LEC established in 28 cm  2 dishes 
were allowed to bind  nsI-PINP or 12SI-TC-PINP at  +4~  for 
2 h. After washing the cultures to remove unbound ligand, the 
incubation temperature was raised to  +37~  and after various 
periods of  incubation, cultures were solubilized  in 1% SDS in PBS 
containing 1 mM PMSF, 2 mM EDTA, 2 mM N-ethylamaleimide, 
and 1 #g/ml pepstatin A. The solubilisates were analyzed by gel 
filtration on Sephacryl  S-300 eluted with PBS containing 0.1% SDS. 
Pulse-chase Studies on the Intracellular Transport of Endocytosed Col- 
lagen.  For morphologicalpulse-chase  studies, monolayer  cultures 
of LEC established on 13-cm diameter round coverslips were in- 
cubated with FITC-PINP (100/~g/ml) at  +4~  for 2 h, washed, 
and chased  for various periods of  time at + 37~  The experiments 
were terminated by fixing the cultures with 2.5% glutaraldehyde 
in PBS. After mounting of the cultures on glass slides, the cells 
were examined in a Zeiss Axiophot  microscope equipped with 
fluorescence optics. Pictures were taken on a Kodak Ektachrome 
film. 
Results 
Elimination of Circulating PINP: Serum tl/2, Distribution and 
Specificity  of Uptake.  The circulatory survival of PINP was 
determined by measuring the decay of blood radioactivity 
after intravenous injection of trace amounts of directly labeled 
~2sI-PINP  or  adduct-labeled  nSI-TC-PINP.  Linear  decay 
plots indicated a very efficient clearance  of both 12sI-PINP 
and I~SI-TC-PlNP (Figs.  1 and 2). Acid-soluble degradation 
products  started  to  appear  in  serum  about  10  min  after 
injection of 12sI-PINP (Fig.  1).  In contrast,  12SI-TC-PINP 
yielded no degradation products in serum. Semilogarithmic 
decay plots revealed a biphasic pattern of elimination (insets, 
Fig.  2).  70-80%  of the injected nSI-TC-PINP was elimi- 
nated during an initial rapid c~-phase with a serum tl/2  of 
0.6-0.8 min. The remaining 20-30%  was diminated with 
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Figure  1.  Uptake  and degradation  of intravenously  injected lzsI-PlNP. 
nSI-labded PlNP (5/~g) was injected intravenously  into a rat, and blood 
samples (25/~1) were  collected  after  various  time periods and immediately 
mixed with 20% TCA to precipitate undegraded  propeptide. (O) Add 
soluble  radioactivity  (left ordinate); (0), acid  precipitable  radioactivity  (right 
ordinate). 
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Figure  2.  Effect  of excess PINP or FSA on elimination of I~I-TC-PINP 
from the circulation.  12SI-TC-PINP  (5/~g) was injected either  alone (a, 
n  =  3) or together with 2 rag PINP (b, n  ~  1) or 5 mg FSA (c, n  - 
4) through the tail vein of rats, and radioactivity  in blood samples was 
plotted against time after injection.  See legend to Fig. 1 for explanatior 
Radioactivity  at  1 min after  injection  was taken  as 100%.  12sI-hbded 
degradation  products  could not be detected. Semilogarithmic  plots ([], 
insets) were used to determine  the slope, B, of the terminal  phase ("8" 
phase"), taken from about 3-10 min after injection. The extrapohted values 
of the curve with slope/~ were subtracted  from the experimental values 
obtained during the initial phase (1-3 min after injection) to give the curve 
with slope a  (I,  insets) describing  the kinetics  of the initial  clearance 
phase ("a-phase'). See Table 1 for pharmacokinetic  data calculated on the 
basis of the a- and B-slopes. 
Figure  3.  Anatomical  distribution  of intravenously  injected  t2SI-TC- 
PINP (a) and lz~I-PINP (b). The animals used in the serum half-life studies 
(Figs. 1 and 2) were analyzed for anatomical distribution  of radioactivity 
50 min after injection. About 80 and 50% of  injected dose were recovered 
in the tissues listed in a and b, respectively Results are expressed as percent 
total radioactivity recovered. In a, lzsI-TC-PINP was injected either alone 
(black  bars, n  -  3), or together with 2 mg PINP (shaded bars, n  -  1) or 
5 mg F'SA (open bars, n  -  4).  Variation was <10%. 
a  tl/2  of 3-4  min  during  a  terminal  slow/~-phase  (insets, 
Fig.  2,  Table  1). 
When  lzsI-PlNP was injected in excess amounts  (2 mg), 
the a-phase could not be detected,  as 100%  of the injected 
isotope  was  eliminated  with  a  monophasic  serum  tl/z~  of 
Table  1.  Elimination  of 125I-TC-PINP  from  the  Circulation  of Rat:  Pharmacokinetic  Parameters 
Proportion  eliminated  with  Proportion  eliminated  with 
Injected material  tt/2c~  (min  +  SD)  tl/2fl  (rain  •  SD)  ti/2ot  (percent  •  SD)  tlnfl  (percent  •  SD) 
~zSI-TC-PINP (10/~g)  0.59  (•  0.05)*  3.33  (•  0.45)s  78.5  (•  6.25)  21.5  (•  6.25) 
(.  =  3)" 
IzSI-TC-PINP (2 rag)  0  4.3  0  100 
(n  =  I) 
1~I-TC-PINP (10/zg) 
+ FSA (5  rag) 
(n  =  4) 
1.08  (•  0.32)  5.08  (+  0.78)  23.9  (+  6.97)  76.13  (_+  6.98) 
" Number of experiments. 
Initial  rapid  a-phase of serum  half-life. 
S Terminal,  slower fl-phase of serum  half-life. 
407  Melkko et ai. Figure 4.  Hepatocelluhr distribution of intravenously injected  12sI- 
PINP. 60 rain after intravenous administration  of 12SI-TC-PlNP  (5 #g) 
LEC, KC, and PC were established in pure cultures. Content of t2sI is 
given either as cpm per 106 cells, expressed in relative units setting cpm 
per 106 KC equal to  1 (a), or as cpm per total cell population in liver 
(b), making use of the fact that the total numbers of KC, LEC, and PC 
in rat liver relate to each other as 1:2.5:7.7 (14). Means from two experi- 
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Figure 5.  Kinetics of endocytosis of 12sI-PlNP  in cultured LEC.  12sI- 
PINP (10 ng) was incubated with cultures  of LEC in 2-cm  2 diameter 
dishes, and cell-associated (mR)  and degraded ([]) ligand-were determined 
after various periods as described in the Materials and Methods  section. 
Extent of endocytosis  (0) is the sum of  cell-associated  and degraded ligand. 
Results are means of triplicates, variation being <10%. 
4.3 min (Table 1). Coinjection with excess amounts of FSA 
(5 rag) reduced the proportion  eliminated  with  o~-kinetics 
to 24%  (tl/2ot  =  1.1  min),  leaving  76%  to be eliminated 
with  a  tl/Zfl  of 5.1  rain. 
Figure 6.  Morphologicalpulse-chase 
study on intracellular transport of en- 
docytosed PlNP. Cultures of  LEC were 
pulsed with FITC-PINP (100/~g/ml) 
for 2 h at 4~  Chasing was performed 
after  removal of unbound ligand by 
washing, and transferring of the cultures 
to 37~  The cultures were fixed after 
chase periods of 0 rain (a), 10 min (b), 
30 min (c), and 60 min (d) and exam- 
ined in a fluorescence microscope. At 
chase start (a) the probe is diffusely dis- 
tributed over the cell surface. After 10 
min (b) the probe  is concentrated  in 
vesicles  of  varying size  and location. The 
endocytic vesicles  containing  the probe 
grow in size  until  30 rain, at which time 
they reach their maximal diameter of 
1/tm or more (c). Note that the larger 
vesicles appear stained only in their pe- 
ripheral aspects (arrow). After 60 rain 
the probe  is concentrated  in smaller, 
densely stained perinuclear vesicles  (d). 
Bar, 10 #m. 
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injection. The liver was the main site of uptake (Fig.  3). 
When 12sI-PINP was injected, uptake in liver  and kidneys 
amounted to 60 and 30%  of the total, respectively  (Fig. 3 
b). In contrast, when lzSI-TC-PINP was administered, nearly 
90% of recovered radioactivity resided in the liver, and <10% 
in the kidneys (Fig. 3 a). Injection of xzSI-TC-PINP together 
with excess amounts of unlabeled PINP (2 rag) or FSA (5 
mg) led to a reduced sequestration in liver corresponding to 
5 and 10%, respectively, the kidneys taking up the spillover 
from liver. Only insignificant amounts were recovered in the 
spleen. 
Pure cultures of various types of liver cells were prepared 
after injection of lzSI-TC-PINP. In LEC, the uptake was 23- 
and 10-fold more active per cell than in KC and PC, respec- 
tively (Fig. 4). We calculated that in the whole liver, the popu- 
lation of LEC was responsible for 78% of the uptake, whereas 
KC and PC took up 1 and 21%, respectively. 
In Vitro Studies: Kinetics of  Endocytosis, Degradation,  Intracel- 
/u/ar Transport,  and Specificity of Uptak~  To study the kinetics 
of endocytosis, trace amounts of labeled PINP were incubated 
with cultures of LEC, and cells and medium was analyzed 
for radioactivity at various time points (Fig. 5). Endocytosis 
proceeded at a rapid rate for the first 4 h of  incubation, reaching 
50% of added amount. At this time point, as much as 40% 
of added label was recovered in the medium as acid-soluble, 
degraded material. 
Intraeellular transport of endocytosed PINP was studied 
with FITC-labded PINP in cultured LEC. After binding at 
4~  only a diffuse staining was observed on the cells. After 
a chase period of 10 min, the probe was observed both in 
peripherally located small vesicles (diameter ,,o0.1/~m)  and 
perinudearly located larger vesicles (diameter 0.1-1.0 #m) 
(Fig. 6 a). At chase intervals exceeding 10 rain (Fig. 6 b) the 
probe disappeared from the peripheral area, and appeared along 
the rim of vesicles that grew in size until about 30 min, at- 
taining diameters of 1/~m or more (Fig. 6 c). These large, 
characteristically looking ring structures decreased in size after 
30 rain, and by 60 rain appeared exclusively as smaller  (di- 
ameter ~  1 #m) densely, intensely stained perinuclear vesicles 
(Fig.  6d). 
The extent of degradation of the ligand in the various en- 
docytic compartments was studied in another set of pulse- 
chase  experiments using PINP labeled  with either 12sI or 
12SI-TC. SDS-solubilized cultures were analyzed by gel filtra- 
tion on Sephacryl S-300 after various chase periods. After 20, 
30, and 60 rain about 30, 50, and 70% of the endocytosed 
propeptide had been transferred to degradation products small 
enough to elute after relative elution position (K,v) 0.75.  A 
substantial proportion of the ligand had been degraded to 
free 12sI after 30 min (Fig.  7). Interestingly, trace amounts 
of ~2sI eluted at a K,v of 1.4 under the conditions used. 
The specificity of endocytosis of PINP was studied by at- 
tempting to inhibit the uptake in cultured LEC using excess 
amounts (10 or 100/~g/ml) of nonlabeled macromolecules. 
PINP and PIIINP inhibited the uptake of 12sI-TC-PINP by 
>95%, whereas FSA and AcLDL exhibited 40 and 50% in- 
hibition (Fig. 8 a). Poly I (10/~g/ml) inhibited endocytosis 
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Figure  7.  Pulse-chase study on 
degradation kinetics of 12sI-PINP. 
These  pulse-chase  studies  were 
carried  out  as  described  in 
Materials  and Methods  section. 
Elution profiles  are given for six 
chasing periods: a, 0 min; b, 20 
min; c,  30  min; d,  60  min; e, 
3  h;  and f,  17  h.  At 0  min all 
ligand elutes as intact propeptide 
(K,v  =  0.4).  To  illustrate in  a 
more exact manner the extent of 
degradation,  the  proportion  re- 
maining as undegraded material 
eluting before K,v 0.75  (shaded 
portion of curves) is given for each 
time point. Complete degradation 
was evident only after several  hours 
of chasing.  Note  that  the  final 
degradation product eluted at the 
same position as flee lz5I- (K~v  ~ 
1.4), whereas only a minor frac- 
tion eluted at Kay  =  1. 
by 74%. Neither LDL, gdatinized human type I collagen, 
heparin,  nor  hyaluronan  affected  the  uptake  of 12SI-TC- 
PINP.  Endocytosis of 12SI-TC-PIIINP (Fig.  8 b),  12SI-FSA 
(Fig.  9 a), or 12SI-TC-AcLDL (Fig.  9 b) was also inhibited 
Figure 8.  Specificity  of endocytosis of 12SI-TC-PINP  and  12Sl-TC- 
PIIINP in LEC. Cultures of  LEC were incubated  with 10 ng 12SI-TC- 
PINP (a)  or  12SI-TC-PIIINP  (b)  for  2 h at  37~  in  2-cm  z  diameter  dishes 
with  or  without  the  presence  of  the  ligands  (100/~g/ml;  poly  I  and  heparin 
were  given as  10  ~tg/ml)  specified  in  the  figure.  Results,  given as  percent 
control,  are  means  of"  triplicate  measurements, 100% corresponds  to  about 
50% of added radioactivity. Variation was <10%. Figure 9.  Specificity of  en- 
docytosis  of mI-FSA and tzSI-TC- 
AcLDL  in LEC. Cultures  of  LEC 
were incubated with 10 ng 12sI- 
FSA (a) or lzSI-TC-AcLDL  (b) for 
2 h at 37~  in 2-cm  2 diameter 
dishes with or without the pres- 
ence of the unlabeled  ligands (100 
/~g/ml) spedfied in  the  figure. 
Since FSA was labeled with l~Sl 
by a conventional method, in- 
tralysosomal  degradation gave  re- 
lease of ml-tyrosine to the me- 
dium.  In  a,  this acid-sduble 
radioactivity is presented  as open 
areas of bars, whereas celi-asso- 
dated radioactivity  is presented  as 
shaded areas. Due to intralyso- 
somal arrest of tzsI-TC after degradation of t2SI-TC-AcLDL, all radioac- 
tivity in b is cell associated. Results, given as percent total, are means of 
triplicate measurements. 100% corresponds  to about 50% of added radio- 
activity. Variation was <10%. 
by the same ligands. PIIINP of human,  bovine, and porcine 
origin  competed for the  same receptors  (Fig.  10). 
Discussion 
A  number of physiological macromolecular  waste prod- 
ucts have been shown to be efficiently eliminated  from the 
circulation by receptor-mediated endocytosis in LEC (for a 
review see reference 4). These cells are more important  than 
the KC in the elimination of connective tissue macromolecules, 
such as ot chains of most collagen types, hyaluronan,  chon- 
droitin sulfate, laminin, nidogen, PICP, and PIIINP. A share 
of work between  the  two cells  of the  hepatic  reticuloen- 
dothelial system seems probable, KC clearing particulate  matter 
and LEC taking up soluble macromolecules. We show here 
that PINP is another major connective tissue--related  protein 
that  is cleared by LEC. 
80% of the PINP is-removed from the bloodstream with 
Figure  10.  Specificity  ofendocytosis  of PlIINP from different species. 
12sI-PIIINP (10 rig) of porcine (a) or bovine  (b) origin were incubated  with 
cultured LEC in 2 cmZ dishes for 2 h at 37~  with or without (Control) 
the presence of" 100 ~g/ml unlabeled human PIIINP (hPII1NP).  (Shaded 
areas) Cell-associated  radioactivity; (open  areas) add-soluble  radioactivity 
(degraded ligand). Results  are means of triplicate measurements, the vari- 
ation being <10%. 
a  ti/2ot  as short  as 0.6 min,  and  the remaining  20%  with 
a  tl/~3  of >3 min.  The capacity of the rapid removal seems 
limited,  as it could be suppressed with large amounts of ei- 
ther PINP itself or FSA, whereas the reserve capacity for the 
slower/3-phase was unsaturable at the amounts of ligand tested 
here. Thus, the total capacity for hepatic uptake of circulating 
PINP is much greater than what is needed under normal phys- 
iological conditions. The ability of FSA to inhibit the uptake 
in vivo suggests that the elimination is mediated by the scav- 
enger receptor  (16). 
Injection of directly labeled IzsI-PINP resulted in the ap- 
pearance of degradation  products in blood after a lag phase 
of about 10 min, suggesting endocytosis and intralysosomal 
degradation of the ligand rather than degradation by extracel- 
lular proteinase(s).  Although the liver was the main site of 
uptake,  the kidneys contained almost 30%  of recovered ra- 
dioactivity after 50 min.  In contrast,  when the protein had 
been coupled to 125I-TC-PINP,  to prevent escape of isotope 
from lysosomes, only about 5% was recovered in the kidneys. 
These findings  support  the idea that  degradation  products 
escaping from the lysosomes at the site of uptake in the liver 
are excreted by the kidneys.  Competitive inhibition  of he- 
patic uptake by excess amounts of PINP or FSA led to a dou- 
bling of the uptake in the kidneys,  suggesting that this organ 
has a marginal but significant ability to clear PINP from the 
circulation. 
Fluorescently labeled PINP visualized two distinct intra- 
cellular endocytic structures in LEC, the stainings of which 
were separated by time. Circular doughnut-shaped structures 
of >0.1-/~m diameter started to appear after 10 min, reaching 
their maximum diameter at about 30 rain.  From these, the 
protein was apparently transferred to smaller,  densely stained 
perinuclear  vesicles,  where virtually all probe was observed 
after 60 min.  These compartments  resemble the large acid 
phosphatase-negative vesicles and the smaller add phosphatase- 
containing vesicles, obviously lysosomes, in which colloidal 
gold-labeled  chondroitin  sulfate proteoglycan  accumulates 
during  the initial  30-40  rain  and later,  respectively,  as re- 
vealed by electron microscopy (17). Three different receptors, 
i.e., the hyaluronan/chondroitin  sulfate receptor (17), the man- 
nose receptor (18), and the PlNP/PIIINP or scavenger receptor 
described here thus seem to mediate similar morphological 
patterns of intracdlular  transport of the endocytosed ligand 
in  LEC. 
Although  PINP  seems  to  be  partially  degraded  in  the 
prelysosomal compartment, complete breakdown only takes 
place after its transfer to the perinuclear vesicles, believed to 
be lysosomes. The aberrant behavior of the final breakdown 
products  of t25I-PlNP  is  explained  by  interactions  of 125I 
with  the gel material. 
The observation that FSA inhibited uptake of PINP in vivo, 
and of both PINP and PIIINP in vitro, along with the finding 
that AcLDL and Poly I competed with PINP for uptake in 
cultured LEC, strongly suggest that the propeptides are en- 
docytosed in LEC via the scavenger receptor. The term scav- 
enger receptor was originally coined to denote a receptor spe- 
des in macrophages that recognizes and endocytoses modified 
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bumin (for a review see reference 19). However, circulating 
AcLDL was later found to be cleared almost exclusively by 
a similar receptor in LEC (20,  21),  and FSA (16) and Poly 
I have also been found to be ligands for this scavenger receptor 
(16). Oxidized LDL, which is likely to be a more physiolog- 
ical modification product than AcLDL, is cleared by both 
KC and LEC (22).  FSA is a purely experimental ligand and 
it has not been possible to find AcLDL in the body. Two 
macrophage scavenger receptor proteins have been doned and 
sequenced (23), but it still remains to be determined whether 
the receptor on LEC is identical with these. Nevertheless, 
our observation that both PINP and PIIINP are cleared by 
the scavenger receptor in LEC, gives the first due to the phys- 
iological function of this receptor. 
The procoflagen propeptides are produced in large amounts 
when collagen is secreted from connective tissue cells, i.e., 
fibroblasts and osteoblasts. Since they fulfill the function of 
preventing premature association of the procoflagen mole- 
cules to fibrils while still being part of the procollagen mole- 
cule, they can be considered as waste products once they have 
been cleaved off. The structure common to these propeptides 
that is recognized by the scavenger receptor remains to be 
determined. The primary structures of PINP and PIIINP are 
dearly different, though homologous, and there is no im- 
munological cross-reactivity. On the other hand, their three- 
dimensional structures are similar and both have an isoelec- 
tric point of about 3 (24-27). AcLDL, FSA, and Poly I are 
also negatively charged. However, our finding that neither 
hyaluronan  nor  heparin,  two  highly  negatively  charged 
glycosaminoglycans, could compete with PINP for uptake, 
suggests that a negative charge per se is not sufficient as a 
signal for uptake. 
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